Biotechnology: Pharmaceutical Preparations

Management ChangeJul 21, 2026, 04:12 PM

Tonix Pharmaceuticals CMO Dr. Gregory Sullivan to Retire

AI Summary

Tonix Pharmaceuticals Holding Corp. announced that Dr. Gregory M. Sullivan, its Chief Medical Officer, will retire from his position. His retirement is effective on August 20, 2026. The company disclosed this information in an 8-K filing.

Key Highlights

Dr. Gregory M. Sullivan will retire from his role as Chief Medical Officer (CMO).

View SEC Filing

TNXP

Biotechnology: Pharmaceutical Preparations

Tonix Pharmaceuticals Holding Corp.

Price Impact